Role of the Gut Microbiota-Brain Axis in Brain Damage in Preterm Infants

Jie Xiao1

  • 1Department of Pathology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, 435000 Huangshi, P. R. China.

Insights

The gut microbiome influences brain development and diseases like white matter injury (WMI) in preterm infants. Understanding the gut-brain axis offers potential microbial treatments for WMI.

Area of Science:

  • Neuroscience
  • Microbiology
  • Developmental Biology

Background:

  • The intestinal microbiome is the largest microbial repository in the body.
  • It plays a critical role in neurological development, aging, and brain disorders, including white matter injury (WMI) in preterm infants.
  • The gut-brain axis facilitates communication between the gut and the nervous system, influencing inflammatory cytokines and oligodendrocyte differentiation.

Purpose of the Study:

  • To review the effects of WMI on intestinal dysbiosis and gut dysfunction.
  • To summarize recent findings on the gut-brain axis in humans and animals concerning brain injury.
  • To highlight the relationship between the microbiota and the brain after acute brain injury.

Main Methods:

  • Literature review of studies on the gut-brain axis and WMI.
  • Analysis of research on microbial metabolites and their impact on brain health.
  • Examination of animal and human data regarding gut microbiota and neurological outcomes.

Main Results:

  • Gut microbes and their metabolites influence inflammatory cytokines, affecting premyelinating oligodendrocyte differentiation and WMI incidence.
  • WMI can lead to intestinal dysbiosis and gut dysfunction, indicating a bidirectional relationship.
  • The gut microflora impacts host metabolism, immunity, and brain health, with implications for disease progression.

Conclusions:

  • The gut microflora-brain axis is a key factor in WMI, particularly in preterm infants.
  • Understanding the communication mechanisms via this axis may reveal new therapeutic targets.
  • Microbial-based interventions hold promise for treating preterm WMI.